These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 7902557
1. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis. Gorczyca W, Kram A, Tuziak T, Darzynkiewicz Z, Melamed MR. Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557 [Abstract] [Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F, Hiroi M, Yamane T, Hara H. Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [Abstract] [Full Text] [Related]
3. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry. Krauss JS, Pantazis CG, Chandler FW. Ann Clin Lab Sci; 1992 Aug; 22(3):189-96. PubMed ID: 1354428 [Abstract] [Full Text] [Related]
4. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M, Porwit A, Tani E, Ost A, Mazur J, Auer G. Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [Abstract] [Full Text] [Related]
5. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Siitonen SM, Kallioniemi OP, Isola JJ. Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759 [Abstract] [Full Text] [Related]
6. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA. J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [Abstract] [Full Text] [Related]
8. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET. Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [Abstract] [Full Text] [Related]
9. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Fontanini G, Pingitore R, Bigini D, Vignati S, Pepe S, Ruggiero A, Macchiarini P. Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306 [Abstract] [Full Text] [Related]
10. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology. Leers MP, Theunissen PH, Ramaekers FC, Schutte B, Nap M. Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487 [Abstract] [Full Text] [Related]
11. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. Visakorpi T. J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498 [Abstract] [Full Text] [Related]
12. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior. Brown HM, Komorowski RA, Wilson SD, Demeure MJ, Zhu YR. Cancer; 1999 Oct 15; 86(8):1583-9. PubMed ID: 10526289 [Abstract] [Full Text] [Related]
13. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA). Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A. Hepatogastroenterology; 1999 Oct 15; 46(26):1187-91. PubMed ID: 10370689 [Abstract] [Full Text] [Related]
14. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. Pich A, Ponti R, Valente G, Chiusa L, Geuna M, Novero D, Palestro G. J Clin Pathol; 1994 Jan 15; 47(1):18-22. PubMed ID: 7907607 [Abstract] [Full Text] [Related]
15. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Teague K, el-Naggar A. Cytometry; 1994 Jan 01; 15(1):21-7. PubMed ID: 7909288 [Abstract] [Full Text] [Related]
16. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas. Turner RR, Layfield LJ, Bishop PC, Epstein AL, Parker JW. Arch Pathol Lab Med; 1989 Aug 01; 113(8):907-11. PubMed ID: 2569301 [Abstract] [Full Text] [Related]
17. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S. Anticancer Res; 1994 Aug 01; 14(3B):1305-12. PubMed ID: 7915093 [Abstract] [Full Text] [Related]
18. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Ebina M, Steinberg SM, Mulshine JL, Linnoila RI. Cancer Res; 1994 May 01; 54(9):2496-503. PubMed ID: 7909277 [Abstract] [Full Text] [Related]
19. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior. Appley AJ, Fitzgibbons PL, Chandrasoma PT, Hinton DR, Apuzzo ML. Neurosurgery; 1990 Jul 01; 27(1):83-96. PubMed ID: 2377285 [Abstract] [Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study. Kram A, Domagała W. Pol J Pathol; 1996 Jul 01; 47(4):183-7. PubMed ID: 9097710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]